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CASEIN, a protein found in milk of several species, is
divided into different chains from 19 to 25 kDa.
Casein is also considered as a source of amino acids
and generating peptides with biological activities
such as opiate, immunostimulating, antibacterial,
peptidase inhibitors, among others.
In this work, Sephadex G-10 chromatography
followed by high-performance liquid chromatogra-
phy isolation purified NZCase TT, an industrial
culture media for tetanus toxin production. In the
first step, four pools were isolated and tested in
different assays: isolated smooth muscle assay
(guinea pig ileum, rat uterus), phagocytosis in vitro
of opsonized sheep red blood cells, and hydrogen
peroxide (H2O2) release from mouse peritoneal
macrophages.
Pool III was the main active pool being able to
potentiate bradykinin action in guinea pig ileum,
stimulating phagocitic activity by resident macro-
phages and increasing H2O2 release from macro-
phages previously activated with bacille Calmette
Gue ´rin.
Using mass spectra the primary structure of the main
peptide from pool III was obtained *
/ INKKI, which
corresponds to b-casein fragment 26 
/30.
The immunostimulating action is probably related to
a direct action in macrophage cells.
Key words: Mastoparan, Casein peptides, Inﬂammation,
Macrophages, Peptide isolation
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Introduction
The proteolytic digestion of large proteins generates
small bioactive peptides.
1 One of these proteins is
casein and, besides its nutritional importance,
revealed after tryptic and quimotryptic hydrolysis
bioactive peptides able to regulate some important
physiological pathways or acting in tissues, such as
arterial blood pressure regulation, respiratory regula-
tion, and in the immunological system among
others.
2 4 These peptides can be generated after
partial digestion and in some conditions could reach
the blood stream, acting in different organs. This
feature is particularly important in the newborn.
5
Peptides with opiate and bradykinin (BK)-potentiat-
ing effects were isolated.
3,6 Other important sources
of bioactive peptides with high activity are found in
venoms (snakes, spiders, scorpions) and in some
insects such as wasp and ants.
7 These peptides have
neurotoxic and peripheral effects including cellular
and immune responses. Recently, a new class of
peptides called mastoparans was isolated from wasps
and bee venoms, and displayed actions on macro-
phages, hemolytic activity and edema.
8,9
Macrophages are phagocytic cells known to play
an important role in the immune response and in the
development of the inflammatory process and
defense reactions, participating in defense reactions
against foreign cells and particles. Macrophage
activation results in functional changes that lead to
bactericidal or tumoricidal activities and the release
of various enzymes, arachidonic acid metabolites and
reactive forms of oxygen, as well as the synthesis of
cytokines.
10,11
Agents that show phagocytosis modulating activity
and increase the functional capacity of the macro-
phage are of potential clinical significance. In this
paper we describe the isolation and characterization
of a new peptide derived from casein hydrolysates.
We observed significant effects on rat arterial blood
pressure and isolated guinea pig ileum, and in
macrophages with an increase in phagocytosis and
H2O2 liberation, showing that the isolated peptide
from casein has a minimum structure that resembles
mastoparan peptides obtained from wasp venoms.
Methods: purification of bioactive peptides
from casein hydrolysates (NZCase)
Molecular ultrafiltration
Ten milliliters of a 10% solution (w/v) of NZCase
in 0.02 M, pH 7.0 of sodium phosphate, was first
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263filtrated with an Ultrafree-15 (Millipore, Bedford, MA,
USA) molecular weight cut-off membrane of 5 kDa
(this procedure was repeated six times). The filtrated
material (8 ml) corresponding to 375 mg of the crude
material was submitted to gel filtration chromatogra-
phy in a Sephadex G-10 column (Amersham Bio-
sciences, Uppsala, Sweden).
Sephadex G-10 gel filtration chromatography
The ultrafiltrated material (8 ml) corresponding to
375 mg of protein was applied to a Sephadex G-10
column (4  /65 cm
2), previously equilibrated with
sodium phosphate buffer solution (0.02 M, pH 7.0)
and eluted with the same buffer with a 12 ml/h flow
rate. Fractions of 3 ml were collected by a LKB-
Pharmacia Redifrac fraction collector and each frac-
tion was read in 280 nm in a Micronal Model B382
spectrophotometer (Micronal, Sa ˜o Paulo, Brazil).
Fractions corresponding to peaks were kept together
in four pools that were lyophilized and stored at
  /208C. The protein of each pool was determined by
the Lowry
12 method and compared with an albumin
standard calibration curve.
High-performance liquid chromatography
purification
After determination of the biological activity on
isolated guinea pig ileum, pool III was submitted to
high-performance liquid chromatography (HPLC)
purification with an HP-1100 series liquid chromato-
graph coupled to an analytical reversed-phase C18
column (4.6 mm  /250 mm) Beckmann 5 m ultra-
sphere ODS (Beckmann, San Ramon, CA, USA) using
a linear gradient of acetonitrile in water /trifluoro-
acetic acid (0.1%) from 0 /45% in 60 min to 45 /90%
in 30 min with a 1 ml/min flow rate, monitored at
214 nm. The main peaks were manually collected,
lyophilized and stored at   /208C.
Peptide sequence
The HPLC-isolated active peak from pool III of the
Sephadex G-10 chromatography was sequenced by
Edman degradation in a Shimadzu sequencer appa-
ratus model PSPQ-1 (Shimadzu, Kioto, Japan) and
the sequence was confirmed by amino acid analy-
sis following the method previously described by
Heiriksson and Meredith,
13 and also by mass spectra
in a triple quadrupole Micromass mass spectrometer
model Quatro II (Micromass, Milford, MA, USA) by
analyzing the mass weight spectra of the generated
peptides and amino acids.
Peptide synthesis
After primary sequence determination of the peptide,
the synthetic peptide was obtained by liquid phase
synthesis, and the identity of the effects obtained with
the natural and synthetic peptide was checked as
described previously by Juliano and Juliano.
14
Peritoneal cell preparation
Animals were anesthetized with ether and killed
through exsanguination by sectioning the cervical
vessels. The peritoneal cavity was washed three times
with cold phosphate-buffered saline (PBS), pH 7.4.
After a gentle massage of the abdominal wall, the
peritoneal fluid, containing resident macrophages,
was collected. Elicited macrophages were obtained
by peritoneal wash 4 days after intraperitoneal
injection of thioglycollate broth (4%). Activated cells
were obtained by peritoneal washing 10 days after
injection (intraperitoneally) of 2 mg of heat-inacti-
vated ONCO-BCG (bacille Calmette Gue ´rin; Butantan
Institute, Sa ˜o Paulo, Brazil). Cell viability was
assessed by the trypan blue exclusion test (  /95%).
Total peritoneal cells were determined in a
Neubauer’s chamber, and the differential counts
were performed in smears stained with Wright and
May Giemsa modified stain methods. For all mea-
surements, samples of individual animals were used.
Phagocytic activity of peritoneal macrophages
A suspension of sheep erythrocytes was diluted in
PBS (0.5%) and mixed (v/v) with rabbit antiserum
against sheep erythrocyte; the mixture was then
incubated for 30 min at 378C. The opsonized
erythrocytes were centrifuged twice, at 184  /g for
10 min, with PBS and suspended with RPMI 1640
medium (0.5%) for the phagocytosis assay. Briefly,
the coverslips containing the adherent and spreading
of peritoneal resident or elicited macrophages
15 were
incubated with 1 ml of RPMI 1640 medium containing
opsonized sheep erythrocytes, for 40 min, at 378C, in
an atmosphere containing 5% CO2. The percentage of
phagocytosis was determined by examination under
a phase contrast microscope, by counting the
percentage of cells that had phagocytosed more
than five particles.
Effect of the peptide on phagocytic activity:
dose /response curve
The effect of peptide over phagocytic activity of
resident peritoneal macrophages was assessed
in vitro. The cover slips containing adhered macro-
phages were incubated with RPMI 1640 medium
(control) or RPMI 1640 containing the peptide (12.5,
25, 50 and 100 mg/ml) at 378C, in an atmosphere
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washed with PBS and prepared for the phagocytosis
assay.
Hydrogen peroxide production
Hydrogen peroxide production (H2O2) was mea-
sured as described by Pick and Mizel
16 and modified
by Russo et al.
17 Briefly, the peritoneal activated cells
were adjusted to 1.5 /2.5  /10
6 cells/ml and centri-
fuged for 10 min at 1000 rpm and 58C. The sediment
was resuspended in 1 ml of phenol red solution,
containing 140 mM NaCl, 10 mM potassium phos-
phate buffer, pH 7.0, with 0.5 mM dextrose, 0.28 mM
phenol red (PRS), and 8.5 U/ml of horseradish
peroxidase for H2O2 detection. The final volume of
7.4 ml was obtained with Hank’s solution. One
hundred microliters of the cell suspension were
plated onto each well of 96-well flat-bottomed tissue
culture plates (Corning, New York, USA) and 10 mlo f
the peptide (5.0 or 10.0 mg) or saline was added and
incubated in a humidified atmosphere at 378C for 1 h.
Vertical row number 1 was left without cells and filled
with 100 ml per well of PRS. The second and third
verticals rows were used for the establishment of
H2O2 standard curves. These wells were covered
with 100 ml of PRS, added to 10 mlo fH 2O2 solution,
resulting in a final concentration of H2O2 ranging
from 5 to 40 mM.
The subsequent rows contained wells covered with
100 ml of PRS in the absence (basal H2O2 production)
or the presence of phorbol myristate acetate (PMA)
(20 ng). After 60 min incubation at 378C, the reaction
was stopped by the addition of 10 ml of 1 N NaOH
solution. H2O2-dependent phenol red oxidation was
measured spectrophotometrically at 620 nm, in a
Labsystem Multiscan apparatus (Labsystem, Helsinki,
Finland). The concentration of H2O2 was calculated
from absorbance measurements, as described by Pick
and Mizel
16 and expressed as nmoles of H2O2 per
milliliter per 2.5  /10
5 cells using the linear regression
calibration curve for each assay.
Isolated guinea pig ileum and isolated rat uterus
assays
The terminal piece of the isolated guinea pig ileum
and the rat uterus (from animals injected 18 h
previously with 1 mg/kg of diethylstilbestrol) were
used. The organs were suspended in a 5 ml chamber
filled with Tyrode’s solution (138 mM NaCl, 2.7 mM
KCl, 1.05 mM MgCl2, 1.8 mM CaCl2, 0.42 mM
NaHPO4, 11.9 mM NaHCO3, and 5.55 mM glucose)
containing atropine sulphate and diphenydramine
(1 mg/ml) at 358C for the isolated guinea pig ileum,
and Jalon solution (154 mM NaCl, 5.63 mM KCl,
0.54 mM CaCl2, 5.95 mM NaHCO3 and 2.8 mM
glucose) maintained at 298C for the uterus. The
solutions were bubbled with air, and the muscle
contractions were recorded on a polygraph coupled
to an isotonic transducer. The substances tested were
preincubated with the smooth muscle for 1 min. The
BK potentiating effect of ‘in vitro’ and ‘in vivo’
experiments were calculated as described previously
by Lebrun et al.
3 One potentiation unit represents
a twofold increase of ileum or uterus contraction for a
constant BK dose. The standard error for these values
was less than 5%.
Statistical analysis
Statistical analysis was performed using analysis of
variation test and the Student t-test and the Student /
Newmann /Keuls test by means of the Primer soft-
ware for statistical analysis first version and the
pB /0.05 significance level was adopted.
Results
From a 10% solution of 8 g of casein digest (NZCase)
previously submitted to molecular ultrafiltration in a
5 kDa Ultrafree membrane, resulting in a 2 g filtrate
that was applied to a Sephadex G-10 gel filtration
chromatography column (4  /65 cm) with a 12 ml/h
flow rate, fractions of 3 ml were collected and the
absorption was determined at 280 nm, resulting in
four main peaks (pool I, pool II, pool III and pool IV)
(Fig. 1). The four pools were tested and the active
pool III was the submitted to HPLC chromatography
(Fig. 2), resulting in an isolated peak that was
sequenced.
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FIG. 1. Puriﬁcation and isolation of casoparan peptide INKKI
from casein hydrolysates (NZCASE). (A) Gel ﬁltration chro-
matography puriﬁcation of NZCase after ultraﬁltration in a
5000 Da membrane in a Sephadex G-10 column (4  /65 cm
2)
eluted with 0.02 M Na2PO4, pH 7.0, solution, monitored at
280 nm, ﬂow rate of 12 ml/h and 3 ml of each fraction. Pool III
(PIII) showed actitivity and was puriﬁed by HPLC.
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After mass spectra of the HPLC-isolated peptide and
analysis with the MassLynx and MaxEnt software, it
was possible to obtain the sequence of the peptide
INKKI that corresponds to the 26 /30 fragment of
the bovine beta-casein. The sequence was confirmed
by sequencing in a PSPQ-1 Shimadzu sequencer by
Edman degradation. The biological effects of the
natural isolated peptide were confirmed using the
synthetic peptide obtained by liquid phase synthesis,
as described previously by Juliano and Juliano.
14
Biological assays
Isolated guinea pig ileum assay was performed with
the pools obtained from Sephadex G-10 gel filtration
chromatography. The pools obtained from Sephadex
G-10 gel filtration chromatography were tested on the
isolated guinea pig ileum to observe the possible
contractile effects or the BK-potentiating activity was
determined as potentiating unity as described in
Methods.
The same effect was observed using the isolated rat
uterus and no intrinsic effect was observed with the
two isolated smooth muscle preparations. Pool II
revealed a dose /response relationship in potentia-
tion of BK effects on isolated guinea pig ileum
(Fig. 3), and from this pool the peptide INKKI was
isolated as the main component by HPLC chromato-
graphy (Fig. 2).
Besides the potentiating effects on BK, the action
of the isolated peptide INKKI isolated after HPLC
chromatography on macrophage functions was
investigated. A dose /response relatioship was
observed on macrophage erythrocyte phagocytosis
with doses ranging from 10 to 100 mg/ml, but over
30 mg/ml a plateau is reached (Table 1). The peptide
INKKI caused increase on phagocytosis by resi-
dent macrophage when compared with the control
(saline). The concentration of the 25 mg/ml induced
the higher increase (80%) in the resident macro-
phage, suggesting that the peptide stimulates the
phagocytic activities (Table 1).
No significant difference was observed when 25 mg
of the INKKI peptide was assessed in vitro on the
phagocytic activity of the resident peritoneal macro-
phages; but the INKKI peptide showed a significant
stimulatory effect on resident macrophages (Fig. 4).
The 5 or 10 mg of INKKI caused an increase in
the stimulated by PMA (38%, 173%) and unstim-
ulated (30%, 38%) production of H2O2 of peritoneal
activated macrophage (Fig. 5A,B).
Discussion
Phagocytosis is a process used by mononuclear
phagocytes to ingest and clear large particles, includ-
ing infectious agents, senescent cells and cellular
debris.
18 Particle internalization is started by the
interaction of specific receptors on the surface of
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FIG. 2. HPLC chromatography of pool III obtained from
Sephadex G-10 chromatography in a C18 analytical
reversed-phase column eluted with a linear gradient of
acetonitritrile 0 /45% in 45 min and 45 /90% acetonitrile in
45 /70 min in TFA 0.1% (in water), ﬂow rate of 1 ml/min
monitored at 214 nm.
FIG. 3. BK-potentiating activity obtained with the isolated
pools (I, II, III and IV) from a Sephadex G-10 column in the
isolated guinea pig ileum. The potentiating-activity (PU)
was calculated as described in Methods. Only pool III
showed signiﬁcant differences when compared with controls
(Student t-test, *pB /0.05).
Table 1. Dose /response activity of casoparan peptide (INKKI)
on phagocytic activity of resident rat peritoneal macrophages
Dose (mg/ml) Stimulation (%)
12.5 17
25 80
50 67
100 47
Results are expressed as percentage of controls.
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particle.
19,20
Several studies have demonstrated the effects of
peptides on the phagocytic activities of macro-
phages.
5,21,22
Data presented herein showed that the peptide
INKKI from HPLC isolation of pool III stimulates
phagocytic activities of resident peritoneal macro-
phages in vitro mediated by the Fc receptor. Resident
macrophages occur in specific sites in normal and
non-inflamed tissues. Elicited macrophages are cells
attracted to a given site because of a particle stimulus,
independent of the developmental stage or func-
tional state of the cells, and activated macrophages
are cells with increased or new functional activities
induced by a given stimulus.
23
The results showed that the stimulant effects of the
peptide depend on the cell activation stage since they
are only observed on resident macrophages, which
are quiescent cells. These cells are responsive to
inflammatory or immunological signals. The increase
of the phagocytosis observed in the resident cells was
similar to the effects observed on elicited macro-
phages, suggesting that the peptide could act as a
macrophage stimulation inducer. This stimulatory
effect was dose dependent and 80% stimulation was
observed in the presence of the casoparan peptide
INKKI 25 mg/ml, while high doses induced a minor
response, suggesting a possible saturation of the
phenomena. Similar results were obtained when the
synthetic peptides were used to assay the phagocytic
activities.
The phagocytosis process stimulates the respira-
tory burst.
24 The generation of reactive oxygen
intermediates such as superoxide and H2O2 is a
practical measuring system for the respiratory burst;
25
and the reactive oxygen intermediates take part in the
microbicidal mechanism used by macrophages and
neutrophils.
20 The peptide INKKI stimulated the
production of hydrogen peroxide only in macro-
phages activated by BCG; this effect was observed in
the presence or absence of PMA. However, the
presence of PMA increases this production. Among
the soluble stimuli, only PMA induces a marked
respiratory burst with an abundant release of
H2O2.
25 The results showed that the peptide as well
as the PMA induce the respiratory burst. The PMA
stimulates the oxidative burst, bypassing the need
for receptor /ligand coupling stimulating a Ca
2 -
dependent protein kinase C.
26,27 Therefore, the
mechanism of the peptide actions remains unknown.
Previous publications report that some peptide
fragments of casein show immunostimulating or
immunomodulator effects.
28 30 A hexapeptide corre-
sponding to the 54 /59 fragment of human b-casein
(VEPIPY) showed a stronger immunostimulating
effect and conferred resistence in experimental
infections with Klebsiella pneumoniae.
31 Moreover,
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FIG. 5. Effects of the casoparan peptide INKKI, 5 mg (A) and
10 mg (B), on H2O2 production by peritoneal macrophages.
The cells were obtained from the peritoneal cavity of mice
injected 10 days before the experiments with BCG. H2O2
(nmol H2O2/2.5  /10
5 cells/ml) was determined in the absence
(dark shading) or in the presence of PMA (light shading). The
results are expressed as the mean9 /standard error of the
mean for 8 /10 animals per group. *pB /0.05, signiﬁcantly
different in comparison between H2O2 production in the
presence of PMA and in the absence of PMA.
FIG. 4. Phagocytic activities of resident (dark shading) or
elicited (light shading) peritoneal macrophages incubated
with casoparan peptide INKKI (25 mg/ml) or saline (control
group). The results are expressed as the mean9 /standard
error of the mean for 8 /10 animals per group. *pB /0.01,
signiﬁcantly different from the control group.
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called Mastoparans, exhibit inflammatory prope-
rties, releasing histamine, provoking edema and cell
migration to the inflammatory site. These peptides
are approximately 1400 Da and have a structure rich
in Ile, Asn and Lys.
32 The isolated pentapeptide
INKKI showed the same motif present in the masto-
parans less the neutral amino acids (Ala, Gli and Leu).
The biological effects include an increase of phago-
cytosis and H2O2 production. These effects happen
even in the presence of PMA, suggesting a specific
pathway for the peptide action. The peptide INKKI
also induced histamine release in rat arterial blood
pressure and isolated guinea pig ileum, since the
effect is blocked by diphenydramine (data not
shown).
The effects displayed by casoparan peptide suggest
that the generation of small peptides from large
proteins with physiological functions is particularly
important. In this particular feature, the peptide
isolated from casein could lead to modulatory effects
over inflammatory cells such as macrophages,
increasing phagocytosis and H2O2 liberation without
the development of inflammation. This aspect con-
sidering the physiological generation in the newborn
could be an adaptive stimulus to the immature
immunological system that is on development.
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